The Oncology Journal Club Episode 16
We’re back to our standard format for today’s episode of The Oncology Journal Club This…
Browsing: NETs
The Oncology Journal Club Episode 13: ESMO Special 1
Today’s episode of The Oncology Journal Club is the first of our ESMO Special Episodes…
Molecular imaging offers insight into therapy outcomes for neuroendocrine tumour patients
A new proof-of-concept study published in the May issue of The Journal of Nuclear Medicine has demonstrated…
New nuclear medicine method shows promise for better detection of neuroendocrine tumours
Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect…
COSA 2017: How do we improve cancer care?
Professor Dorothy Keefe, from the University of Adelaide, presented at the Clinical Oncology Society of…
New mutations related to hereditary neuroendocrine tumours
Pheochromocytomas and paragangliomas are rare neuroendocrine tumours with a strong hereditary component. Half the genes…
Updated phase II results of sulfatinib for neuroendocrine tumours
Data from the ongoing phase Ib/II clinical trial of sulfatinib in patients with advanced neuroendocrine…
Australian researchers reveal genetic links underlying neuroendocrine pancreatic cancer
An Australian-led international research effort has revealed that genetic changes normally linked to breast, colon…
New drug in development shows improved progression-free survival for patients with advanced metastatic midgut neuroendocrine tumours
A new therapy in development for the treatment of midgut neuroendocrine tumours, a rare type…
Long-term experience supports efficacy and safety of PRRT for treating neuroendocrine tumours
More than ten years of published clinical data and personal experience using peptide receptor radionuclide…